Wednesday, April 29, 2026 2:07:37 PM
🏛️ THE FORENSIC RESET: RESPONSE TO RIZONA
rizona, you are looking at the Historical Ledger (The US Cesspool) while we are looking at the SEC-Approved Audit (The London Vault).
## THE "1B+ SHARES" VS. THE "339M AUDIT"
Yes, the company has "Issued" 1B+ shares over years on the US-based 1058 rail. However, as every forensic analyst knows: You cannot audit what you cannot see. 1. The Problem: The US OTC market is a "Black Box" filled with synthetic churn, naked shorting, and failed settlements. Within that 1.6B you see on your screen, there is no way to tell a "Title Deed" from an "IOU."
2. The Sieve: To get the April 16, 2026 SEC EFFECT, the company had to provide a sanitized count. They did this by pouring the float through the LSE / CREST Bridge.
3. The Result: Only 339,842,519 shares were physically validated and moved to the P6007/GB rail.
## WHAT HAPPENED TO THE REST?
If the company says they issued 1B+, but the SEC only grants "Effect" to 339M, where is the difference?
The Answer: It is the Synthetic Overhang. It is the debt, the naked shorts, and the "Ghost" shares that exist on the Market Makers' books but did not survive the London Audit.
The SEC didn't sign off on 1.6B shares on April 20th—they signed off on 339M.!!!!!!!!!!!!! If you trust your broker's screen (1.6B) over the SEC's own Notice of Effectiveness (339M), you are trusting the "Madoff Statement" over the actual bank vault.
Verdict: The 1B+ is the Un-Sanitized History; the 339M is the Audited Future. The extraction is complete.
rizona, you are looking at the Historical Ledger (The US Cesspool) while we are looking at the SEC-Approved Audit (The London Vault).
## THE "1B+ SHARES" VS. THE "339M AUDIT"
Yes, the company has "Issued" 1B+ shares over years on the US-based 1058 rail. However, as every forensic analyst knows: You cannot audit what you cannot see. 1. The Problem: The US OTC market is a "Black Box" filled with synthetic churn, naked shorting, and failed settlements. Within that 1.6B you see on your screen, there is no way to tell a "Title Deed" from an "IOU."
2. The Sieve: To get the April 16, 2026 SEC EFFECT, the company had to provide a sanitized count. They did this by pouring the float through the LSE / CREST Bridge.
3. The Result: Only 339,842,519 shares were physically validated and moved to the P6007/GB rail.
## WHAT HAPPENED TO THE REST?
If the company says they issued 1B+, but the SEC only grants "Effect" to 339M, where is the difference?
The Answer: It is the Synthetic Overhang. It is the debt, the naked shorts, and the "Ghost" shares that exist on the Market Makers' books but did not survive the London Audit.
The SEC didn't sign off on 1.6B shares on April 20th—they signed off on 339M.!!!!!!!!!!!!! If you trust your broker's screen (1.6B) over the SEC's own Notice of Effectiveness (339M), you are trusting the "Madoff Statement" over the actual bank vault.
Verdict: The 1B+ is the Un-Sanitized History; the 339M is the Audited Future. The extraction is complete.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
